Abel Hall LLC’s Erasca ERAS Stock Holding History

Abel Hall LLC’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Sell	16,724 -223	-1%	-$3.19K	0.05%	467
2026 Q1	$274K	Buy	16,947 +1,265	+8%	+$15K	0.06%	454
2025 Q4	$58.3K	Buy	+15,682	New	+$44.1K	0.01%	646

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Abel Hall LLC's ERAS Position: Q2 2026 in Review

Abel Hall LLC reduced its Erasca (ERAS) stake by 1.3% in Q2 2026, selling an estimated $3.19K and leaving 16,724 shares worth $306K. The position accounts for 0.05% of the portfolio, ranked #467.

Abel Hall LLC first reported a position in ERAS in Q4 2025 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

Abel Hall LLC held 16,724 shares of Erasca worth $306K as of Q2 2026.
Abel Hall LLC sold 223 Erasca shares in Q2 2026, an estimated $3.19K.
Erasca made up 0.05% of Abel Hall LLC's portfolio in Q2 2026, its #467 holding.
Abel Hall LLC first reported a position in Erasca in Q4 2025 and has held it in 3 quarters since.
256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.